Published in Respir Physiol Neurobiol on September 19, 2016
Effects of different early rehabilitation techniques on haemodynamic and metabolic parameters in sedated patients: protocol for a randomised, single-bind, cross-over trial. BMJ Open Respir Res (2017) 0.75
In Vivo Assessment of Mitochondrial Dysfunction in Clinical Populations Using Near-Infrared Spectroscopy. Front Physiol (2017) 0.75
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11
General considerations for lung function testing. Eur Respir J (2005) 7.99
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003) 3.44
Peripheral muscle alterations in non-COPD smokers. Chest (2008) 2.58
Principles, techniques, and limitations of near infrared spectroscopy. Can J Appl Physiol (2004) 2.36
Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J (2004) 1.84
Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc (1998) 1.77
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD (2008) 1.65
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.63
Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. J Biomed Opt (2007) 1.56
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax (2004) 1.38
Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax (2002) 1.37
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J (2002) 1.33
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax (2007) 1.32
Simultaneous in vivo measurements of HbO2 saturation and PCr kinetics after exercise in normal humans. J Appl Physiol (1985) (1994) 1.20
Skeletal muscle oxidative metabolism in sedentary humans: 31P-MRS assessment of O2 supply and demand limitations. J Appl Physiol (1985) (2004) 1.15
Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med (2000) 1.06
Noninvasive evaluation of skeletal muscle mitochondrial capacity with near-infrared spectroscopy: correcting for blood volume changes. J Appl Physiol (1985) (2012) 1.04
Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Exerc (2001) 1.04
Kinetic control of oxygen consumption during contractions in self-perfused skeletal muscle. J Physiol (2011) 1.04
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J (2005) 1.03
Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? Muscle Nerve (2013) 1.03
Noninvasive monitoring of deterioration in skeletal muscle function with forearm cast immobilization and the prevention of deterioration. Dyn Med (2004) 0.99
The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? Am J Respir Crit Care Med (2008) 0.98
A cross-validation of near-infrared spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic resonance spectroscopy. J Appl Physiol (1985) (2013) 0.97
Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target. Exp Physiol (2013) 0.97
Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology (2006) 0.97
Near-infrared assessments of skeletal muscle oxidative capacity in persons with spinal cord injury. Eur J Appl Physiol (2013) 0.94
Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements. J Physiol (2014) 0.90
Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol (2012) 0.89
On-off asymmetries in oxygen consumption kinetics of single Xenopus laevis skeletal muscle fibres suggest higher-order control. J Physiol (2012) 0.88
Ischemic preconditioning of the muscle improves maximal exercise performance but not maximal oxygen uptake in humans. J Appl Physiol (1985) (2011) 0.86
Muscle deoxygenation in the quadriceps during ramp incremental cycling: Deep vs. superficial heterogeneity. J Appl Physiol (1985) (2015) 0.84
Reproducibility of near-infrared spectroscopy measurements of oxidative function and postexercise recovery kinetics in the medial gastrocnemius muscle. Appl Physiol Nutr Metab (2013) 0.84
Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med (2000) 0.81
Each-step activation of oxidative phosphorylation is necessary to explain muscle metabolic kinetic responses to exercise and recovery in humans. J Physiol (2015) 0.80